In a previous study on selected patients with BC and/or ovarian cancer from the south of Tunisia, the overall frequency of the BRCA1/2 germline mutations was 14.17%, which is lower than ours [38]. The gene discussed is BRCA1; the disease is ovarian carcinoma.